Who owns BioMarin Pharmaceutical Inc.?
Institutional ownership of BMRN from SEC Form 13F filings across 351 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
351
13F holders
$7.43B
value, 2026 filers
67.9%
of shares outstanding (131.2M sh)
57
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of BMRN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 20.4M | $1.17B | 0.0% | 10.6% | +3.2% |
| 2 | PRIMECAP MANAGEMENT CO/CA/ | 14.2M | $812.0M | 0.5% | 7.3% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 8.7M | $500.3M | 0.0% | 4.5% | -49.4% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.6M | $494.9M | 0.0% | 4.5% | +4.2% |
| 5 | NORGES BANKNEW | 8.2M | $469.7M | 0.0% | 4.2% | new |
| 6 | VIKING GLOBAL INVESTORS LP | 7.6M | $435.8M | 1.2% | 3.9% | +7.9% |
| 7 | FMR LLC | 4.8M | $276.0M | 0.0% | 2.5% | +35.2% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 3.9M | $223.9M | 0.0% | 2% | +2.4% |
| 9 | Capital Research Global Investors | 3.5M | $200.5M | 0.0% | 1.8% | +0.4% |
| 10 | MILLENNIUM MANAGEMENT LLC | 2.1M | $118.5M | 0.0% | 1.1% | -31.2% |
| 11 | Assenagon Asset Management S.A. | 1.8M | $100.8M | 0.1% | 0.9% | -8.3% |
| 12 | Sixth Street Partners Management Company, L.P.NEW | 1.6M | $92.5M | 16.0% | 0.8% | new |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.6M | $92.5M | 0.0% | 0.8% | +1.8% |
| 14 | FIRST TRUST ADVISORS LP | 1.6M | $91.9M | 0.1% | 0.8% | -4.0% |
| 15 | NORTHERN TRUST CORP | 1.6M | $89.2M | 0.0% | 0.8% | -1.8% |
| 16 | MORGAN STANLEY | 1.5M | $86.1M | 0.0% | 0.8% | +13.9% |
| 17 | Swedbank AB | 1.3M | $75.2M | 0.1% | 0.7% | +66.0% |
| 18 | UBS Group AG | 1.3M | $73.6M | 0.0% | 0.7% | -14.1% |
| 19 | DNB Asset Management AS | 1.3M | $72.6M | 0.2% | 0.7% | +3.8% |
| 20 | Caisse de depot et placement du Quebec | 1.2M | $70.7M | 0.1% | 0.6% | +30.8% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $70.0M | 0.0% | 0.6% | +2.5% |
| 22 | GOLDMAN SACHS GROUP INC | 1.2M | $68.8M | 0.0% | 0.6% | +216.6% |
| 23 | AMERIPRISE FINANCIAL INC | 1.2M | $66.3M | 0.0% | 0.6% | -1.3% |
| 24 | Bank of New York Mellon Corp | 1.2M | $66.1M | 0.0% | 0.6% | +0.9% |
| 25 | CITADEL ADVISORS LLC | 1.1M | $64.2M | 0.0% | 0.6% | -75.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.